Advertisement
Canada markets open in 3 hours 37 minutes
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7270
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    83.13
    +0.40 (+0.48%)
     
  • Bitcoin CAD

    89,303.51
    +4,669.81 (+5.52%)
     
  • CMC Crypto 200

    1,333.70
    +21.07 (+1.63%)
     
  • GOLD FUTURES

    2,397.60
    -0.40 (-0.02%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,440.50
    -106.75 (-0.61%)
     
  • VOLATILITY

    19.53
    +1.53 (+8.50%)
     
  • FTSE

    7,834.70
    -42.35 (-0.54%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6817
    -0.0004 (-0.06%)
     

How Is Biogen’s Alzheimers’ Disease Pipeline Positioned in 2019?

How Is Biogen’s Alzheimers’ Disease Pipeline Positioned in 2019?

Gilead Sciences or Biogen: Which Is the Better Biotech Pick?(Continued from Prior Part)Failed programOn March 21, Biogen (BIIB) issued a press release announcing the discontinuation of its Phase 3 trials ENGAGE and EMERGE evaluating its leading